Anti programmed cell death receptor 1 trang 1 tải miễn phí từ tailieunhanh

"Anti programmed cell death receptor 1" trang 1 - tải miễn phí từ tailieunhanh

Ray of dawn: Anti-PD-1 immunotherapy enhances the chimeric antigen receptor T-cell therapy in Lymphoma patients

Ray of dawn: Anti-PD-1 immunotherapy enhances the chimeric antigen receptor T-cell therapy in Lymphoma patients

9 6 1

Safety, activity, and pharmacokinetics of camrelizumab in advanced Asian melanoma patients: A phase I study

Safety, activity, and pharmacokinetics of camrelizumab in advanced Asian melanoma patients: A phase I study

10 26 1

A case report of eyelid Merkel cell carcinoma occurring under treatment with nivolumab for a lung adenocarcinoma

A case report of eyelid Merkel cell carcinoma occurring under treatment with nivolumab for a lung adenocarcinoma

5 67 0

Establishing a whole blood CD4+ T cell immunity measurement to predict response to anti-PD-1

Establishing a whole blood CD4+ T cell immunity measurement to predict response to anti-PD-1

10 8 1

Concomitant use of pembrolizumab and entinostat in adult patients with metastatic uveal melanoma (PEMDAC study): Protocol for a multicenter phase II open label study

Concomitant use of pembrolizumab and entinostat in adult patients with metastatic uveal melanoma (PEMDAC study): Protocol for a multicenter phase II open label study

7 65 0

Steven-Johnson syndrome: A rare but serious adverse event of nivolumab use in a patient with metastatic gastric adenocarcinoma

Steven-Johnson syndrome: A rare but serious adverse event of nivolumab use in a patient with metastatic gastric adenocarcinoma

7 6 1